EUVIMEDEUVIMED entdecken
Open Access

Systemic Lupus Erythematosus Mortality Among Decedents Aged ≥15 Years—United States, 2018–2023

Danielle Dawson, Kurt J Greenlund, Kamil E Barbour

Arthritis Care & Research · 2026

DOI: 10.1002/acr.70042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis Care & Research, 2026. Verfasst von Danielle Dawson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centers for Disease Control and Prevention, Atlanta, Georgia. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Systemic lupus erythematosus (SLE) is a chronic autoimmune condition that can lead to death. To examine SLE as an underlying and contributing cause of death, the Centers for Disease Control and Prevention (CDC) analyzed 2018 to 2023 mortality data for persons aged ≥15 years overall and by age, sex, race and ethnicity, and region.

Methods

Death certificate data for persons aged ≥15 years with any mention of SLE ( International Classification of Diseases, Tenth Revision [ICD‐10] code M32) were analyzed using the CDC Wide‐ranging Online Data for Epidemiologic Research (WONDER) system. We calculated age‐adjusted death rates and assessed patterns by sex, age, race and ethnicity, and region. Underlying and contributing causes of death were evaluated using ranked cause‐of‐death lists and ICD‐10 subchapters.

Results

During 2018 to 2023, 14,936 deaths had any mention of SLE listed on the death certificates. Of these deaths, 6,414 (42.9%) listed SLE as the underlying cause. The age‐adjusted SLE mortality rate per million population was greater among females (5.97) than males (1.16), non‐Hispanic African American persons (10.70) than persons of other non‐Hispanic racial groups (range 2.46–5.62), Hispanic persons (3.98) than non‐Hispanic persons (3.59), and people in the South (4.37) than people in other regions. When SLE was listed as a contributing cause of death, the leading underlying causes were heart disease (0.93), cancer (0.56), and COVID‐19 (0.51). The overall age‐adjusted SLE mortality rates were significantly higher in 2020 and 2021 than in all other study years, indicating the likely impact of the COVID‐19 pandemic on SLE mortality.

Conclusion

Overall management of SLE, comorbidities, and infections in patients with SLE, as well as interventions targeting groups (eg, African American persons) disproportionately impacted by SLE, may reduce overall SLE mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicHumansFemaleUnited StatesMaleMiddle AgedAdultAdolescentCause of DeathYoung AdultAgedDeath CertificatesAge DistributionAged, 80 and over

Autor:innen und Institutionen

  • Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee.

Zitieren

APA

Dawson, D., Greenlund, K. J., & Barbour, K. E. (2026). Systemic Lupus Erythematosus Mortality Among Decedents Aged ≥15 Years—United States, 2018–2023. Arthritis Care & Research. https://doi.org/10.1002/acr.70042

Vancouver

Dawson D, Greenlund KJ, Barbour KE. Systemic Lupus Erythematosus Mortality Among Decedents Aged ≥15 Years—United States, 2018–2023. Arthritis Care & Research. 2026. doi:10.1002/acr.70042

BibTeX
@article{Dawson2026,
  author = {Dawson, Danielle and Greenlund, Kurt J and Barbour, Kamil E},
  title = {Systemic Lupus Erythematosus Mortality Among Decedents Aged ≥15 Years—United States, 2018–2023},
  journal = {Arthritis Care & Research},
  year = {2026},
  doi = {10.1002/acr.70042}
}
Kostenlos starten →